1. A phase 2a randomized, double‐blind, placebo‐controlled, sequential dose‐escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate‐to‐severe psoriasis. (19th June 2015) Authors: Papp, K.; Pariser, D.; Catlin, M.; Wierz, G.; Ball, G.; Akinlade, B.; Zeiher, B.; Krueger, J.G. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2a randomized, double‐blind, placebo‐controlled, sequential dose‐escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate‐to‐severe psoriasis. (19th June 2015) Authors: Papp, K.; Pariser, D.; Catlin, M.; Wierz, G.; Ball, G.; Akinlade, B.; Zeiher, B.; Krueger, J.G. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase 2a randomized, double‐blind, placebo‐controlled, sequential dose‐escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate‐to‐severe psoriasis. (1st September 2015) Authors: Papp, K.; Pariser, D.; Catlin, M.; Wierz, G.; Ball, G.; Akinlade, B.; Zeiher, B.; Krueger, J.G. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A study of dupilumab in the treatment of adolescents with eczema. (1st January 2020) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A study of dupilumab in the treatment of adolescents with eczema. (2nd January 2020) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0363 Coadministration of asp015k, a novel janus kinase inhibitor, with methotrexate demonstrates tolerability and lack of pharmacokinetic interactions in patients with rheumatoid arthritis. (23rd January 2014) Authors: Zhu, T.; Oda, K.; Valluri, U.; Moore, B.; Cao, Y.; Chindalore, V.; Akinlade, B. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A898 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Conjunctivitis in dupilumab clinical trials. (1st September 2019) Authors: Akinlade, B.; Guttman‐Yassky, E.; de Bruin‐Weller, M.; Simpson, E.L.; Blauvelt, A.; Cork, M.J.; Prens, E.; Asbell, P.; Akpek, E.; Corren, J.; Bachert, C.; Hirano, I.; Weyne, J.; Korotzer, A.; Chen, Z.; Hultsch, T.; Zhu, X.; Davis, J.D.; Mannent, L.; Hamilton, J.D. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: e69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Conjunctivitis in dupilumab clinical trials. (7th May 2019) Authors: Akinlade, B.; Guttman‐Yassky, E.; de Bruin‐Weller, M.; Simpson, E.L.; Blauvelt, A.; Cork, M.J.; Prens, E.; Asbell, P.; Akpek, E.; Corren, J.; Bachert, C.; Hirano, I.; Weyne, J.; Korotzer, A.; Chen, Z.; Hultsch, T.; Zhu, X.; Davis, J.D.; Mannent, L.; Hamilton, J.D. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension. (1st January 2020) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension. (8th October 2019) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗